Shopping Cart 0
Cart Subtotal
USD 0

Endo International Plc (ENDP) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies. It sells generic products principally in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women's health, among others. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrinology and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors, to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc (ENDP)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Endo International Plc, Medical Equipment, Deal Details 11

Private Equity 11

Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For USD 130 Million 11

Partnerships 12

Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12

Debt Offering 13

Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13

Auxilium Pharma Completes Public Offering Of Notes Due 2018 For USD 350 Million 14

Asset Transactions 15

Trendlines Acquires Intellectual Property from Endo 15

Acquisition 16

Par Formulations to Acquire Wintac 16

Par Pharma Acquires Innoteq for USD27 Million 17

Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18

Endo Health Solutions Completes Acquisition Of Paladin Labs For USD 1.6 Billion 19

Par Pharma Acquires JHP Group for USD488 Million 22

Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23

Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24

Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For USD 26.2 Million 25

Endo International Plc-Key Competitors 26

Endo International Plc-Key Employees 27

Endo International Plc-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Strategy And Business Planning 31

Jul 21, 2017: Endo to Restructure Manufacturing Network 31

Financial Announcements 32

Aug 08, 2018: Endo reports second-quarter 2018 financial results 32

May 08, 2018: Endo Reports First-Quarter 2018 Financial Results 34

Feb 27, 2018: Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results 36

Nov 09, 2017: Endo Reports Third-Quarter 2017 Financial Results 38

Aug 08, 2017: Endo Reports Second-Quarter 2017 Financial Results 40

May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 42

Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 45

Corporate Communications 48

Aug 02, 2018: Endo announces appointment of Laure Park as senior vice president investor relations and corporate affairs 48

Nov 08, 2017: Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram 49

Legal and Regulatory 50

Apr 02, 2018: Endo Agrees to Extend Temporary Stay of FDA Litigation 50

Aug 07, 2017: Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims 51

Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 52

Other Significant Developments 53

Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 53

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Endo International Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Endo International Plc, Medical Equipment, Key Facts, 2017 2

Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Endo International Plc, Deals By Market, 2012 to YTD 2018 9

Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For USD 130 Million 11

Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12

Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13

Auxilium Pharma Completes Public Offering Of Notes Due 2018 For USD 350 Million 14

Trendlines Acquires Intellectual Property from Endo 15

Par Formulations to Acquire Wintac 16

Par Pharma Acquires Innoteq for USD27 Million 17

Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18

Endo Health Solutions Completes Acquisition Of Paladin Labs For USD 1.6 Billion 19

Par Pharma Acquires JHP Group for USD488 Million 22

Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23

Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24

Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For USD 26.2 Million 25

Endo International Plc, Key Competitors 26

Endo International Plc, Key Employees 27

Endo International Plc, Other Locations 29

Endo International Plc, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Endo International Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies. It sells generic products principally in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women's health, among others. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrinology and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors, to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc (ENDP)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Endo International Plc, Medical Equipment, Deal Details 11

Private Equity 11

Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For USD 130 Million 11

Partnerships 12

Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12

Debt Offering 13

Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13

Auxilium Pharma Completes Public Offering Of Notes Due 2018 For USD 350 Million 14

Asset Transactions 15

Trendlines Acquires Intellectual Property from Endo 15

Acquisition 16

Par Formulations to Acquire Wintac 16

Par Pharma Acquires Innoteq for USD27 Million 17

Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18

Endo Health Solutions Completes Acquisition Of Paladin Labs For USD 1.6 Billion 19

Par Pharma Acquires JHP Group for USD488 Million 22

Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23

Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24

Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For USD 26.2 Million 25

Endo International Plc-Key Competitors 26

Endo International Plc-Key Employees 27

Endo International Plc-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Strategy And Business Planning 31

Jul 21, 2017: Endo to Restructure Manufacturing Network 31

Financial Announcements 32

Aug 08, 2018: Endo reports second-quarter 2018 financial results 32

May 08, 2018: Endo Reports First-Quarter 2018 Financial Results 34

Feb 27, 2018: Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results 36

Nov 09, 2017: Endo Reports Third-Quarter 2017 Financial Results 38

Aug 08, 2017: Endo Reports Second-Quarter 2017 Financial Results 40

May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 42

Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 45

Corporate Communications 48

Aug 02, 2018: Endo announces appointment of Laure Park as senior vice president investor relations and corporate affairs 48

Nov 08, 2017: Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram 49

Legal and Regulatory 50

Apr 02, 2018: Endo Agrees to Extend Temporary Stay of FDA Litigation 50

Aug 07, 2017: Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims 51

Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 52

Other Significant Developments 53

Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 53

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Endo International Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Endo International Plc, Medical Equipment, Key Facts, 2017 2

Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Endo International Plc, Deals By Market, 2012 to YTD 2018 9

Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For USD 130 Million 11

Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12

Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13

Auxilium Pharma Completes Public Offering Of Notes Due 2018 For USD 350 Million 14

Trendlines Acquires Intellectual Property from Endo 15

Par Formulations to Acquire Wintac 16

Par Pharma Acquires Innoteq for USD27 Million 17

Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18

Endo Health Solutions Completes Acquisition Of Paladin Labs For USD 1.6 Billion 19

Par Pharma Acquires JHP Group for USD488 Million 22

Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23

Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24

Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For USD 26.2 Million 25

Endo International Plc, Key Competitors 26

Endo International Plc, Key Employees 27

Endo International Plc, Other Locations 29

Endo International Plc, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Endo International Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.